When will First Phosphate’s ADRs be uplisted to the Nasdaq Global Market?

First Phosphate’s ADRs are scheduled to be uplisted at the opening of trading on August 10, 2026. The announcement was published on August 7, 2026.

What will happen to First Phosphate’s Level 1 ADRs on the OTCQX market?

Effective August 10, 2026, First Phosphate’s Level 1 ADRs will be delisted from the OTCQX market and automatically converted into Level 2 ADRs tradeable on the Nasdaq Stock Exchange under ticker symbol “PHOS”.

What ticker symbol will First Phosphate use for its Nasdaq Level 2 ADRs?

First Phosphate’s Nasdaq Level 2 ADRs will trade under ticker symbol “PHOS”. The ADRs have CUSIP 33611D301 and ISIN US33611D3017.

What is the ADR ratio for First Phosphate?

The First Phosphate ADR ratio remains set at ten (10) First Phosphate common shares for each (1) First Phosphate ADR.

Where are First Phosphate’s securities listed and what are the ticker symbols?

First Phosphate states that its securities are listed on Nasdaq under “PHOS”, the CSE under “PHOS”, the OTCQX under “FRSPF” and the FSE under “KD0”. The Nasdaq Level 2 ADR programme is described as complementary to the other company listings and does not affect the currently listed common shares on the OTCQX, CSE or FSE.

Will First Phosphate issue new shares or raise capital through the ADR uplisting?

No new shares will be issued and no capital will be raised in connection with First Phosphate’s ADR uplisting. The company states that the Level 2 ADR programme does not constitute a new offering of securities.

How long can investors convert First Phosphate common shares into ADRs at no cost?

Participants may continue to convert First Phosphate common shares into ADRs at no cost until December 31, 2026. The conversions are facilitated by The Bank of New York Mellon, which is the depositary bank for the ADR programme.

How can investors convert First Phosphate common shares into ADRs?

Investors can convert First Phosphate common shares into ADRs by instructing their broker or custodian to deliver the common shares through CDS to BNY’s safekeeping account at CIBC Mellon. BNY facilitates ADR issuance and cancellation in accordance with instructions received from market participants.

Who is the depositary bank for First Phosphate’s ADR programme?

The Bank of New York Mellon, referred to as BNY, is the current depositary bank for First Phosphate’s ADR programme. The underlying First Phosphate common shares are held in custody by BNY.

Where is First Phosphate’s ADR deposit agreement available?

First Phosphate’s ADR programme operates under a deposit agreement filed with the United States Securities and Exchange Commission. The company provides the SEC filing at https://www.sec.gov/Archives/edgar/data/2108542/000101915526000028/0001019155-26-000028-index.htm.

Who should investors contact about First Phosphate ADR issuances and cancellations?

Questions about First Phosphate ADR issuances and cancellations should be directed to canadadrconversions@bny.com. BNY facilitates the issuance and cancellation process for the programme.

What is the purpose of First Phosphate’s ADR programme?

First Phosphate describes ADRs as negotiable US securities representing a non-US company’s equity. It states that ADRs trade freely in global markets and facilitate cross-border trading.

Home
News Intelligence
First Phosphate Corp
First Phosphate sets Nasdaq Global Market uplisting for ADRs under PHOS

Back to all First Phosphate Corp press releases

First Phosphate Corp

CSE:PHOS
FSE:KD0
NASDAQ:PHOS
OTCQX:FRSPF

First Phosphate sets Nasdaq Global Market uplisting for ADRs under PHOS

Published Friday, 07 August 2026

Get alerts

Plain English summaries when First Phosphate Corp announces news.

At a glance

Company: First Phosphate Corp
Listings: CSE:PHOS, FSE:KD0, NASDAQ:PHOS, OTCQX:FRSPF
Announcement type: Corporate update
Published: Friday, 07 August 2026
Source announcement: firstphosphate.com

FAQSIR Generated from this announcement View original release below for safe harbor and regulatory notices

Announcement Summary

First Phosphate Corp. (NASDAQ: PHOS) (CSE: PHOS) (OTCQX: FRSPF) (FSE: KD0) announced that its American Depositary Receipts will be uplisted to Nasdaq Global Market.

The ADRs will trade as Level 2 ADRs under ticker symbol PHOS, effective at the opening of trading on August 10, 2026.
The ADR ratio remains ten (10) First Phosphate common shares for each (1) First Phosphate ADR.
Level 1 ADRs will be delisted from OTCQX and automatically converted to Level 2 ADRs.
Participants may convert common shares into ADRs at no cost through The Bank of New York Mellon until December 31, 2026.
The program is not a new securities offering; no additional shares will be issued and no capital will be raised.

The uplisting does not affect common shares listed on OTCQX under FRSPF, CSE under PHOS, or FSE under KD0. BNY remains the depositary bank.

Investor FAQs

First Phosphate announced that its ADRs will be uplisted to the Nasdaq Global Market as Level 2 ADRs under ticker symbol “PHOS”. The change is scheduled to take effect at the opening of trading on August 10, 2026.

Source announcement

Company: First Phosphate Corp
Title: First Phosphate Announces Uplisting of American Depositary Receipt (ADR) to Nasdaq Global Market Under Ticker Symbol PHOS
Published: Friday, 07 August 2026
Source site: firstphosphate.com

Read the source announcement on firstphosphate.com

FAQSIR's summary and investor FAQs are generated by AI from the text of this announcement alone, without information from other sources.

Figures, forecasts and other claims are the announcement's, not FAQSIR's. FAQSIR does not independently verify them.

Read the original press release

Full text as published, unedited.

Loading the original release…

Important Notice And Disclaimer

This article was generated by an artificial intelligence system from an announcement published by the issuer. It has not been independently researched, verified, or edited by a journalist, and no person holds editorial responsibility for its wording.

The issuer named in this article has not paid for this page and has no commercial relationship with its publisher. This is an unpaid evaluation preview produced from announcements the issuer published publicly, and it is not independent editorial coverage.

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Ask about this announcement

Answers drawn only from this announcement

Reading the announcement…